| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/31/2005 | EP1567192A1 Methods of treatment of ulcerative colitis with anti-cd3 antibodies |
| 08/31/2005 | EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 08/31/2005 | EP1078064B1 Compounds from moraxella catarrhalis |
| 08/31/2005 | EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 08/31/2005 | EP0721345B1 Prostatic cancer vaccine |
| 08/31/2005 | CN1662558A Antibodies specific for human cd22 and their therapeutic anddiagnostic uses |
| 08/31/2005 | CN1662557A Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| 08/31/2005 | CN1662556A Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 08/31/2005 | CN1662554A Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 08/31/2005 | CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 08/31/2005 | CN1662254A ALCAM and ALCAM modulators |
| 08/31/2005 | CN1661012A Miniaturized polypeptide of anti EB Virus tumour, application and preparation method |
| 08/31/2005 | CN1661009A Product of transegenic plant for expressing coat protein of human rotavirus and application for preventing infant diarrhea |
| 08/31/2005 | CN1660912A Anti IL-8 monoclonal antibody, sequence of its variable region and application |
| 08/31/2005 | CN1660911A Connective tissue growth factor fragments and methods and uses thereof |
| 08/31/2005 | CN1660910A Method for producing tetanic immunoglobulin |
| 08/31/2005 | CN1660909A Neutralization monoclonal antibody of white spot syndrome virus and preparation method |
| 08/31/2005 | CN1660908A Monoclonal antibody of virus receptor of anti leukoplakia disease and preparation method |
| 08/31/2005 | CN1660907A Monoclonal antibody of anti lymphocyst virus of and preparation method |
| 08/31/2005 | CN1660906A Technique for extracting secretion type immunoglobulin sig A in extractive of human colostrum |
| 08/31/2005 | CN1660905A Method for distilling and purifying lgG in colostrums of cow |
| 08/31/2005 | CN1660904A Method for preparing antibody of clenbuteral hydrochloride |
| 08/31/2005 | CN1660900A CUDR as biomarker for cancer progression and therapeutic response |
| 08/31/2005 | CN1660444A Immunity coupler of containing monoclonal antibody Fab' segment of anti TV type collagenase poly glutamic acid-blemycin A5 |
| 08/31/2005 | CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment |
| 08/31/2005 | CN1660426A Methods for inhibiting brain tumor growth |
| 08/31/2005 | CN1217000C Exhiting method of preparing antibody by antigen utilizing bacteriophage exhibiting technique |
| 08/31/2005 | CN1216995C DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses |
| 08/31/2005 | CN1216992C Immunomodulators |
| 08/31/2005 | CN1216991C Human guanosine monophophate reductase and its coding sequence and preparation method |
| 08/31/2005 | CN1216914C Humanized antibody with specificity t HBV surface antigen PRE-S1 and its producing process |
| 08/31/2005 | CN1216910C Novel liver regeneration related protein, its code sequence and application |
| 08/31/2005 | CN1216902C Specific protein of SARS virus, clinical detection method and kit |
| 08/31/2005 | CN1216641C Monoclonal human matural antibodies |
| 08/31/2005 | CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease |
| 08/30/2005 | US6936706 In vitro and in vivo diagnosis, immunization, and therapy of neoplastic tumors, particularly carcinomas, by means of specifically targeted analogue peptides containing amino acid sequences encompassing CDRs of different species |
| 08/30/2005 | US6936705 nucleic acid sequence that is an insert of a clone selected from the group consisting of: yeast artificial chromosome, isolable from a transformant identified by international deposit number FERM BP-4271; BP-4273; BP-4274 |
| 08/30/2005 | US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 08/30/2005 | US6936698 Genetically engineered immunoglobulin; for use in treatment of hematopoietic defects |
| 08/30/2005 | US6936695 Manufacture and expression of large structural genes |
| 08/30/2005 | US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon |
| 08/30/2005 | US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping |
| 08/30/2005 | US6936691 Secreted protein HCE3C63 |
| 08/30/2005 | US6936585 Corticotropin releasing factor 2 receptor agonists |
| 08/30/2005 | US6936464 Immune responses to fusion proteins |
| 08/30/2005 | US6936453 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/30/2005 | US6936440 Selecting ligand agonists and antagonists |
| 08/30/2005 | US6936426 Administering an interleukin-16 or a RANTES activity inhibitor |
| 08/30/2005 | US6936425 Attenuated salmonella SP12 mutants as antigen carriers |
| 08/30/2005 | US6936424 Materials and methods for detection and treatment of breast cancer |
| 08/30/2005 | US6936422 Staphylococcus culture; genetic engineering |
| 08/30/2005 | US6936263 Th1 inducing natural adjuvant for heterologous antigens |
| 08/30/2005 | US6936261 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 08/30/2005 | US6936259 For therapy and prophylaxis of bacterial infections |
| 08/30/2005 | US6936258 Staphylococcus antigen and vaccine |
| 08/30/2005 | US6936254 Method of inducing fetal hemoglobin synthesis |
| 08/30/2005 | US6936251 Detection using antibodies |
| 08/30/2005 | US6936248 Methods of inhibiting GPR-9-6 function |
| 08/30/2005 | US6936247 Filariid anti-P22U antibodies |
| 08/30/2005 | US6936246 Passive immunization of ASCR for prion disorders |
| 08/30/2005 | CA2294647C Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/30/2005 | CA1341488C Precursor antigens for human retorvirus (hiv-2) envelope glycoproteins, and immunologically related antigens |
| 08/25/2005 | WO2005078087A1 Antibody targeting osteoclast-associated protein |
| 08/25/2005 | WO2005078075A2 Hybrid proteins of active-site serine beta-lactamase |
| 08/25/2005 | WO2005077984A1 Process for producing organic compound and antibody for use therein |
| 08/25/2005 | WO2005077983A2 Modulating p38 kinase activity |
| 08/25/2005 | WO2005077982A1 Less immunogenic binding molecules |
| 08/25/2005 | WO2005077981A2 Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES |
| 08/25/2005 | WO2005077980A2 Soluble tcr-like molecules and their uses |
| 08/25/2005 | WO2005077979A1 Method for obtaining antibodies requiring the use of a set of electromagnetic fields |
| 08/25/2005 | WO2005077978A2 Antibody for diagnosing and treating neuropsychiatric diseases, in particular schizophrenia, depression and bipolar affective disorders |
| 08/25/2005 | WO2005077462A2 Cd70 inhibition for the treatment and prevention of inflammatory bowel disease |
| 08/25/2005 | WO2005077417A1 Inhibition of factor b, the alternative complement pathway and methods related thereto |
| 08/25/2005 | WO2005077416A2 Lipid rafts and clostridial toxins |
| 08/25/2005 | WO2005077414A1 Highly concentrated liquid formulations of anti-egfr antibodies |
| 08/25/2005 | WO2005077413A1 Ctgf as target for the therapy of diabetic nephropathy |
| 08/25/2005 | WO2005077130A2 A method for the removal of aggregate proteins from recombinant samples using ion exchange chromatography |
| 08/25/2005 | WO2005077106A2 Monoclonal antibody based biomarker discovery and development platform |
| 08/25/2005 | WO2005077090A2 Improved methods of producing antibody conjugates |
| 08/25/2005 | WO2005077071A2 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | WO2005077007A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 08/25/2005 | WO2005076965A2 Anti-cd3 and antigen-specific immunotherapy to treat autoimmunity |
| 08/25/2005 | WO2005076958A2 Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders |
| 08/25/2005 | WO2005076843A2 Methods and compositions for treating tumors and metastatic disease |
| 08/25/2005 | WO2005063816A3 Monovalent antibody fragments useful as therapeutics |
| 08/25/2005 | WO2005058967A8 Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof |
| 08/25/2005 | WO2005056599A3 Antibodies that specifically bind pms2 |
| 08/25/2005 | WO2005047320A3 Equine p-selection glycoprotein ligand-1 and uses thereof |
| 08/25/2005 | WO2005044307A3 Methods of therapy for b cell-related cancers |
| 08/25/2005 | WO2005044304A3 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 08/25/2005 | WO2005040217A3 Antibodies having a mutated amino acid residue at position 268 (ch2 region) in constant regions |
| 08/25/2005 | WO2005037868A3 Methods of treating nfat-related disorders |
| 08/25/2005 | WO2005037194A3 Collagen interactions with prostate cancer cells |
| 08/25/2005 | WO2005033134A3 Secreted protein therapeutics and uses thereof |
| 08/25/2005 | WO2005028510A3 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity |
| 08/25/2005 | WO2005027963A3 METHODS AND COMPOSITIONS FOR THE GENERATION OF A PROTECTIVE IMMUNE RESPONSE AGAINTS SARS-CoV |
| 08/25/2005 | WO2005019831A3 Methods for reducing complexity of a sample using small epitope antibodies |
| 08/25/2005 | WO2005005635A3 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 08/25/2005 | WO2004113500A3 B7s1: an immune modulator |